SCHEMBL4036839

SCHEMBL4036839

COc1ccc(C(NC(=O)c2ccccc2)c2cc(Cl)c3cccnc3c2O)cc1OC

nearest known ligand 0.85

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 7/20 0.85
KMT2A Q03164 6/20 0.85
MEN1 O00255 5/20 0.85
HTT P42858 5/20 0.85
SMN1; SMN2 Q16637 5/20 0.85
TDP1 Q9NUW8 2/20 0.85
L3MBTL1 Q9Y468 1/20 0.85
NPC1 O15118 6/20 0.80
RAB9A P51151 6/20 0.80
HSP90AA1 P07900 3/20 0.75
KDM4E B2RXH2 2/20 0.75
MITF O75030 1/20 0.75
TP53 P04637 6/20 0.71
MCL1 Q07820 1/20 0.70
SLC2A1 P11166 1/20 0.67
THRB P10828 1/20 0.67
POLB P06746 1/20 0.66
KDM4A O75164 1/20 0.63
EGLN1 Q9GZT9 1/20 0.63
KDM4C Q9H3R0 1/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15783141 0.92 LMNA (1.00) LMNAKMT2AMEN1HTTSMN1; SMN2
SCHEMBL26241487 0.91 LMNA (0.82) LMNAKMT2AMEN1HTTSMN1; SMN2
SCHEMBL4034263 0.91 NPC1 (0.80) LMNAKMT2AMEN1HTTSMN1; SMN2
SCHEMBL2153027 0.89 NPC1 (1.00) LMNAKMT2AMEN1HTTSMN1; SMN2
SCHEMBL4043428 0.88 NPC1 (0.78) LMNAKMT2AMEN1HTTSMN1; SMN2
SCHEMBL4044460 0.87 NPC1 (0.81) LMNAKMT2AMEN1HTTSMN1; SMN2
SCHEMBL1814308 0.86 MEN1 (0.86) LMNAKMT2AMEN1HTTSMN1; SMN2
SCHEMBL608538 0.86 NPC1 (1.00) LMNAKMT2AMEN1HTTSMN1; SMN2
SCHEMBL1811921 0.86 ADAMTS5 (0.82) LMNAKMT2AMEN1HTTSMN1; SMN2
SCHEMBL15783174 0.85 RAB9A (1.00) LMNAKMT2AMEN1HTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2079699-A1 QUINOLINE DERIVATIVES Envivo Pharmaceuticals, Inc. (US) 2009-07-22 EP claimed
WO-2008014602-A1 QUINOLINE DERIVATIVES ENVIVO PHARMACEUTICALS, INC. (US) 2008-02-07 WO claimed
EP-2079699-A1 QUINOLINE DERIVATIVES Envivo Pharmaceuticals, Inc. (US) 2009-07-22 EP disclosed
WO-2008014602-A1 QUINOLINE DERIVATIVES ENVIVO PHARMACEUTICALS, INC. (US) 2008-02-07 WO disclosed